Literature DB >> 18407596

Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

Gulsum-Ozlem Elpek1, Guzide-Ayse Gokhan, Sevgi Bozova.   

Abstract

AIM: To investigate the significance of Thrombospondin-1 (TSP-1) expression and its relationship with angiogenesis during experimental fibrosis.
METHODS: Cirrhosis was induced in male Wistar rats by intraperitoneal administration of diethyl nitrosamine (DEN). The serial sections from liver tissues were stained with anti-CD34 and anti-TSP-1 antibodies before being quantitated by light microscopy.
RESULTS: Our results showed that of TSP-1 expression gradually increases according to the severity of fibrosis (P < 0.05). Moreover, TSP-1 expression was found to be correlated with angiogenesis (P < 0.05).
CONCLUSION: The correlative evidence of the link between TSP-1 and fibrosis or angiogenesis provided by this study suggests that besides its role as a strong promoter of transforming growth factor-beta 1 (TGF-beta 1), TSP-1 might have an additional role in liver fibrogenesis by stimulating angiogenesis and this protein could be a potential target to prevent fibrogenesis in chronic inflammatory diseases of the liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407596      PMCID: PMC2703847          DOI: 10.3748/wjg.14.2213

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Thrombospondins: multifunctional regulators of cell interactions.

Authors:  J C Adams
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells.

Authors:  G Taraboletti; L Morbidelli; S Donnini; A Parenti; H J Granger; R Giavazzi; M Ziche
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

4.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

6.  Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats.

Authors:  Y Q Wang; K Ikeda; T Ikebe; K Hirakawa; M Sowa; K Nakatani; N Kawada; K Kaneda
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

7.  Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.

Authors:  Christophe Corpechot; Veronique Barbu; Dominique Wendum; Nils Kinnman; Colette Rey; Raoul Poupon; Chantal Housset; Olivier Rosmorduc
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

8.  Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density.

Authors:  H U Kasper; M Ebert; P Malfertheiner; A Roessner; C J Kirkpatrick; H K Wolf
Journal:  Virchows Arch       Date:  2001-02       Impact factor: 4.064

9.  Liver regeneration is an angiogenesis- associated phenomenon.

Authors:  Tom A Drixler; Mathys J Vogten; Ewan D Ritchie; Theo J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest; Inne H M Borel Rinkes
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

10.  Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.

Authors:  H Yoshiji; S Kuriyama; J Yoshii; Y Ikenaka; R Noguchi; D J Hicklin; Y Wu; K Yanase; T Namisaki; M Yamazaki; H Tsujinoue; H Imazu; T Masaki; H Fukui
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

View more
  5 in total

Review 1.  Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev; Dmitry Vladimirovich Belov
Journal:  World J Hepatol       Date:  2016-06-08

Review 2.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

3.  Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.

Authors:  Rana V Smalling; Don A Delker; Yuxia Zhang; Natalia Nieto; Michael S McGuiness; Shuanghu Liu; Scott L Friedman; Curt H Hagedorn; Li Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-27       Impact factor: 4.052

4.  Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics.

Authors:  Bin Zhang; Zi Wang; Bin Deng; Xiaoqiong Wu; Jing Liu; Xueping Feng
Journal:  Proteome Sci       Date:  2013-07-11       Impact factor: 2.480

5.  Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density.

Authors:  Jing Zhang; Wei Yang; Duanyun Zhao; Yun Han; Bo Liu; Hua Zhao; Hongbo Wang; Quanzhong Zhang; Guangming Xu
Journal:  Oncol Lett       Date:  2013-10-29       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.